IQVIA™ Real-World Insights Bibliography
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults – A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study) |
Author(s): Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas |
Affiliations(s): University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States |
Publication(s): |
Document Type(s): Article, |
Countries: Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA, |
Click here for the abstract |
C: Y: |
Infectious disease, 2021 |
|
L: A: |
English Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study, |
|
|
|
|
Budget impact analysis of Biphasic Insulin Aspart in the treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective |
Author(s): Tan SC1, Matzen P2, Yeo LN2 |
Affiliations(s): 1 IMS Asia Pacific, Singapore 2 Novo Nordisk Pharma Malysia, Kuala Lumpur, Malaysia |
Publication(s): ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014
|
Document Type(s): Poster, |
Countries: Malaysia, |
C: Y: |
Diabetes, 2014 |
|
L: A: |
English Budget impact, |
|
|
|
|
Estimating the Costs of Diabetes Mellitus: An Analysis in Malaysia |
Author(s): Todorova L1, Hnoosh A2, Bloomfield E2, Shiu ML3 |
Affiliations(s): 1 Novo Nordisk International Operations, Zurich, Switzerland 2 IMS Health, London, UK 3 Novo Nordisk Pharma Operations (BAOS) Sdn. Bhd., Kuala Lumpur, Malaysia |
Publication(s): ISPOR 5th Asia-Pacific Conference, 2-4 September 2012, Taipei, Taiwan.
|
Document Type(s): Abstract, |
Countries: Malaysia, |
Click here for the abstract |
C: Y: |
Diabetes, 2012 |
|
L: A: |
English Cost analysis, |
|
|
|
|
The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries. |
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3 |
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore |
Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
|
Document Type(s): Abstract, Poster, |
Countries: India, Malaysia, Singapore, South Korea, Thailand, |
C: Y: |
Ophthalmology, 2012 |
|
L: A: |
English Cost effectiveness, |
|
|
|
|
Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries. |
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3 |
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore |
Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
|
Document Type(s): Abstract, Poster, |
Countries: Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand, |
C: Y: |
Ophthalmology, 2012 |
|
L: A: |
English Burden of illness, |
|
|
|
|
Asthma control and its direct healthcare costs: findings using a derived Asthma Control Test (ACT) score in eight Asia-Pacific areas. |
Author(s): Lai CKW1 Kuo S-H2 de Guia T3 Lloyd A4, Williams AE5, Spencer MD5 |
Affiliations(s): 1 Dept of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong 2 National Taiwan University Hospital, Taipei, Taiwan 3 Philippine Heart Centre, Quezon City, The Philippines 4 Fourth Hurdle Consulting Ltd, London, UK 5 GlaxoSmithKine R&D, Greenford, UK |
Publication(s): European Respiratory Review 2006; 15:(98): 24-29
|
Document Type(s): Manuscript in preparation, |
Countries: China, Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Vietnam, |
C: Y: |
Respiratory disease, 2006 |
|
L: A: |
English Cost of illness, |
|
|
|
|
|
|